Evidence map›Paper›PMID 35566761›Full record

ArticleJournal of clinical medicine2022

Outcome Analysis in Elective Electrical Cardioversion of Atrial Fibrillation Patients: Development and Validation of a Machine Learning Prognostic Model.

Jean C Nuñez-Garcia, Antonio Sánchez-Puente, Jesús Sampedro-Gómez, Victor Vicente-Palacios, Manuel Jiménez-Navarro, Armando Oterino-Manzanas, Javier Jiménez-Candil, P Ignacio Dorado-Diaz, Pedro L Sánchez

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Atrial fibrillation in continuous flow-left ventricular assist device (CF-LVAD) patients: impact on pathophysiology.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2025
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jean C Nuñez-GarciaDepartment of Cardiology, Hospital Universitario de Salamanca-IBSAL, 37007 Salamanca, Spain.ORCID 0000-0003-0061-3643
Antonio Sánchez-PuenteDepartment of Cardiology, Hospital Universitario de Salamanca-IBSAL, 37007 Salamanca, Spain.ORCID 0000-0002-6167-2041
Jesús Sampedro-GómezDepartment of Cardiology, Hospital Universitario de Salamanca-IBSAL, 37007 Salamanca, Spain.
Victor Vicente-PalaciosDepartment of Cardiology, Hospital Universitario de Salamanca-IBSAL, 37007 Salamanca, Spain.
Manuel Jiménez-NavarroDepartment of Cardiology, Hospital Virgen de la Victoria-IBIMA, 29010 Malaga, Spain.ORCID 0000-0002-6759-0514
Armando Oterino-ManzanasDepartment of Cardiology, Hospital Universitario de Salamanca-IBSAL, 37007 Salamanca, Spain.
Javier Jiménez-CandilDepartment of Cardiology, Hospital Universitario de Salamanca-IBSAL, 37007 Salamanca, Spain.
P Ignacio Dorado-DiazDepartment of Cardiology, Hospital Universitario de Salamanca-IBSAL, 37007 Salamanca, Spain.ORCID 0000-0002-8344-6328
Pedro L SánchezDepartment of Cardiology, Hospital Universitario de Salamanca-IBSAL, 37007 Salamanca, Spain.ORCID 0000-0002-1402-0526

Funding

Instituto de Salud Carlos III CB16/11/00374
6 · The paper itself

Abstract

Background: The integrated approach to electrical cardioversion (EC) in atrial fibrillation (AF) is complex; candidates can resolve spontaneously while waiting for EC, and post-cardioversion recurrence is high. Thus, it is especially interesting to avoid the programming of EC in patients who would restore sinus rhythm (SR) spontaneously or present early recurrence. We have analyzed the whole elective EC of the AF process using machine-learning (ML) in order to enable a more realistic and detailed simulation of the patient flow for decision making purposes. Methods: The dataset consisted of electronic health records (EHRs) from 429 consecutive AF patients referred for EC. For analysis of the patient outcome, we considered five pathways according to restoring and maintaining SR: (i) spontaneous SR restoration, (ii) pharmacologic-cardioversion, (iii) direct-current cardioversion, (iv) 6-month AF recurrence, and (v) 6-month rhythm control. We applied ML classifiers for predicting outcomes at each pathway and compared them with the CHA2DS2-VASc and HATCH scores. Results: With the exception of pathway (iii), all ML models achieved improvements in comparison with CHA2DS2-VASc or HATCH scores (p < 0.01). Compared to the most competitive score, the area under the ROC curve (AUC-ROC) was: 0.80 vs. 0.66 for predicting (i); 0.71 vs. 0.55 for (ii); 0.64 vs. 0.52 for (iv); and 0.66 vs. 0.51 for (v). For a threshold considered optimal, the empirical net reclassification index was: +7.8%, +47.2%, +28.2%, and +34.3% in favor of our ML models for predicting outcomes for pathways (i), (ii), (iv), and (v), respectively. As an example tool of generalizability of ML models, we deployed our algorithms in an open-source calculator, where the model would personalize predictions. Conclusions: An ML model improves the accuracy of restoring and maintaining SR predictions over current discriminators. The proposed approach enables a detailed simulation of the patient flow through personalized predictions.

Indexed as

atrial fibrillationelectrical cardioversionmachine-learningpharmacologic cardioversionrhythm control

Identifiers

PMID35566761
PMCPMC9101912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.